Establishment Labs Holdings  logo
Establishment Labs Holdings ESTA
$ 65.47 -1.22%

Annual report 2025
added 02-27-2026

report update icon

Establishment Labs Holdings Net Debt 2011-2026 | ESTA

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Establishment Labs Holdings

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
174 M 131 M 149 M 110 M -51.1 M -33.9 M 10.7 M -30.3 M 13.2 M 37.7 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
174 M -51.1 M 51 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Medical devices industry

Issuer Net Debt Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
38.7 M - - $ 1.77 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
1.64 B $ 13.08 2.19 % $ 1.77 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-3.31 M - 3.58 % $ 2.21 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
252 K - 37.08 % $ 85.7 M usaUSA
Avinger Avinger
AVGR
-16.3 M - -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-230 M - - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
-32.4 M - 1.37 % $ 20.5 M usaUSA
BIOLASE BIOLASE
BIOL
6.1 M - -13.19 % $ 166 K usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
6.46 M - -5.86 % $ 30.6 M usaUSA
Conformis Conformis
CFMS
-26.2 M - - $ 16.4 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
11 M $ 0.61 -2.58 % $ 38 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-22.5 M - - $ 475 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-22.8 M $ 3.22 - $ 121 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
-64.6 M - 0.15 % $ 844 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
3.85 M $ 11.21 -4.84 % $ 317 M usaUSA
Globus Medical Globus Medical
GMED
-511 M $ 93.7 -1.24 % $ 12.7 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
-5.12 M $ 2.12 -1.85 % $ 1.29 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
1.8 M - 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
-97.8 M - - $ 10.2 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
230 M - -4.14 % $ 702 M usaUSA
Electromed Electromed
ELMD
-10.5 M $ 26.0 -1.48 % $ 220 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
2.62 M - -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
-4.38 M - -0.57 % $ 7.12 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-31.6 M - -1.42 % $ 435 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
-282 M $ 63.41 -1.23 % $ 3.46 B britainBritain
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.02 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-2.3 M - 0.03 % $ 1.58 B israelIsrael
LENSAR LENSAR
LNSR
-10.2 M $ 5.21 2.36 % $ 62.3 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
5.72 M - - $ 462 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
-31.6 M $ 1.28 0.79 % $ 52.1 M usaUSA
Neovasc Neovasc
NVCN
-4.95 M - - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
83.3 M $ 15.82 -2.29 % $ 371 M usaUSA
Butterfly Network Butterfly Network
BFLY
-65.9 M $ 5.48 2.81 % $ 1.16 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.8 M - - $ 955 M usaUSA
Insulet Corporation Insulet Corporation
PODD
468 M $ 188.31 -0.66 % $ 13.2 B usaUSA
Delcath Systems Delcath Systems
DCTH
-42.5 M $ 10.84 - $ 388 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-5.23 M $ 1.08 1.89 % $ 18.3 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
802 M $ 37.87 -1.23 % $ 1.18 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
-433 M $ 55.07 -2.2 % $ 1.62 B usaUSA
Sintx Technologies Sintx Technologies
SINT
-898 K $ 2.35 -4.86 % $ 6.52 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
1.18 B $ 85.35 -0.78 % $ 2.96 B usaUSA
PAVmed PAVmed
PAVM
710 K $ 8.4 -6.67 % $ 5.63 M usaUSA
Invacare Corporation Invacare Corporation
IVC
299 M - - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
-2.32 B $ 83.46 -0.94 % $ 48.8 B usaUSA
Stryker Corporation Stryker Corporation
SYK
11 B $ 329.01 0.46 % $ 126 B usaUSA
MiMedx Group MiMedx Group
MDXG
-148 M $ 3.34 -2.62 % $ 494 M usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
-75.4 M $ 24.24 -3.31 % $ 554 M usaUSA
Nevro Corp. Nevro Corp.
NVRO
93.4 M - - $ 217 M usaUSA